Skip to search.
 TSX Down 0.04% TSX Ventures Down 0.04%

Titan Pharmaceuticals Inc. (TTNP)

-OTC BB
0.71 Up 0.04(5.97%) Mar 31, 3:59PM EDT
|Pre-Market : NaN
Add to Portfolio
Prev Close:0.67
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:2.30
Beta:2.78
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.44 - 0.87
Volume:0
Avg Vol (3m):451,074
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
TTNPUp 5.97%N/A
LLYDown 1.65%77.05B
JNJDown 0.94%279.72B
PFEDown 0.60%213.22B

Key Statistics

Forward P/E (1 yr):7.89
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.05
Quarterly EPS Est (Mar-15) :-0.01
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Titan Pharmaceuticals, Inc., a specialty pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback